We've been so busy with our educational activities and breaking news in the cardiorenal and cardiometabolic health spheres that our April Newsletter is a bit late! Here's what's happening this month in our fast-moving field, brought to you courtesy of Cardiometabolic Health Congress (CMHC).

Don't miss this interview with George L. Bakris, MD, as he discusses the landscape of new and emerging therapies for your patients with resistant hypertension, specifically in the context of impaired kidney function or kidney failure.

"There's the aldosterone synthase inhibitor, baxdrostat, which has gotten very promising data in people with normal kidney function and is now being steadied in people with advanced kidney disease for resistant hypertension." - Dr. Bakris

Explore a compilation of provider stories from those who seek CMHC's educational initiatives because, as you'll read, they were tired, frustrated, and nearing the end of their already-limited resources. Hear how providers from multiple medical disciplines decided to shed the restrictions of their specialty and embrace CMHC's whole-patient concept of cardiometabolic care. Then, share your story to raise awareness and bring new practitioners into the cardiometabolic medicine family via response to this email or on social by using #IAmCardiometabolicMedicine!

Have you booked your trip for the Spring conference from CMHC? If not, hurry and register for the upcoming Taming the Flames: Inflammation in Cardiometabolic Disease so you can join us in Orlando on May 19-20, 2023! Due to booming popularity, rooms at the Gaylord Palms Resort & Convention Center have SOLD OUT, but don't worry, we are working with nearby hotels to secure more discounted rooms for attendees. Contact us at info@cardiometaboolichealth.org for help booking your stay in Orlando next month!

We are thrilled to welcome Erin D. Michos, MD, MPH back as co-chair of the annual Women’s Cardiometabolic Health and Wellness Masterclass! On August 17-20, 2023, Dr. Michos and colleagues will gather in Southern California to explore the significant differences in risk factors, symptom presentation, preventive strategies, and treatment for cardiometabolic diseases in women. Register for the interactive educational experience to join Dr. Michos and other renowned experts for the retreat-style conference focusing on evidence-based recommendations and best-care strategies!

"We do a huge disservice if we don't treat women for decades and decades of their life and let atherosclerosis go unchecked during childbearing years. It's better to have targeted brief interruptions of treatment during pregnancy than to leave these women untreated. Women often spend all their energy taking care of everybody else in their life, but they also need to pay attention to their own heart health." - Dr. Michos

Developments, approvals, publications, and research in the cardiorenal metabolic field are released at what sometimes feels like a dizzying pace! Being a part of one of the fastest-moving disciplines in health care is exciting, but if you need a little help keeping up with the buzz, CMHC is here for you! Browse the stories we found to be the most compelling this month:

• Obesity Affects Respiration in Women
• Effects of In-Utero COVID-19 Exposure on Infant Growth
• Sanofi Joins Lilly and Novo to Cut Insulin Prices
• Interpersonal Racism Drives Heart Disease Risk for Black Women
• FDA Approves First-in-class Evkeeza (evinacumab-dgnb) for Young Children with Ultra-rare Form of High Cholesterol
• Obesity, more common now in young patients, adds to the burden of cardiorenal syndrome